2022
DOI: 10.7759/cureus.25382
|View full text |Cite
|
Sign up to set email alerts
|

In an Emergency Setting, What Is the Best Intramuscular Pharmacological Treatment to Give to an Agitated Geriatric Patient?

Abstract: Herein, we describe an agitated geriatric patient who suffered an adverse outcome due to treatment for agitation in an emergency setting. This led to the prompt review of the current literature on best-practice medication to use in this population. After careful review, the authors recommend olanzapine as the first-line medication for agitation due to its lower risk-averse effect profile when compared to other medications used for this patient population.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…In general, the prescription and administration of PRN injections of antipsychotics and benzodiazepines in acutely agitated patients may vary by clinician, institutionspecific policies, and availability of pharmacological agents [24,28]. A pitfall of this, as noted by a recent case study, is that clinicians may give undue preference to older, more familiar medications even in situations where newer agents may be more suitable [29]. As such, further research is needed to clarify some of the ambiguity surrounding current practices in the administration of PRN psychotropics for dementia-associated agitation.…”
Section: Introductionmentioning
confidence: 99%
“…In general, the prescription and administration of PRN injections of antipsychotics and benzodiazepines in acutely agitated patients may vary by clinician, institutionspecific policies, and availability of pharmacological agents [24,28]. A pitfall of this, as noted by a recent case study, is that clinicians may give undue preference to older, more familiar medications even in situations where newer agents may be more suitable [29]. As such, further research is needed to clarify some of the ambiguity surrounding current practices in the administration of PRN psychotropics for dementia-associated agitation.…”
Section: Introductionmentioning
confidence: 99%